OVARIAN CANCER SCREENING
ANCHOR LEAD: USING TWO METHODS MAY ALLOW MANY MORE WOMEN TO BE SCREENED FOR OVARIAN CANCER
Using a blood marker called CA125 followed by transvaginal ultrasound may be an effective way to screen women for ovarian cancer. That’s the conclusion of a recent study of over 200,000 women in the Lancet using both techniques in a low risk population. Deborah Armstrong, an ovarian cancer expert at Johns Hopkins, says this method still isn’t ready for prime time.
ARMSTRONG: At this point in time we are not recommending it for the general population, but I do think that at some point in time, hopefully as we get data from very large groups of patients like this group from the United Kingdom with over 200,000 women, who are not at high risk, as we get more information from groups like this perhaps we might be able to start doing ovarian cancer screening. :20
Armstrong emphasizes that transvaginal ultrasound, not abdominal ultrasound, must be used to get the best visualization of the ovaries. At Johns Hopkins, I’m Elizabeth Tracey.